Tau-directed therapeutics
Tau-directed treatments are in trials. None is an approved dementia medicine on this atlas.
Overview
Because tau tracks clinical progression, it is a major pipeline theme. Benefit and safety remain trial questions.
How it works
Antisense, antibody, or small-molecule approaches aimed at tau protein.
Latest papers
topQuery for this technology: (TITLE:"Tau-directed therapeutics" OR ABSTRACT:"Tau-directed therapeutics") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Tau-directed therapeutics, not a curated reading list.
Similar pages
not linked directly; found by shared links- PathwayAmyloid and tau cascade (simplified)
Shares Tau, Alzheimer’s disease and the tag dementia-atlas.
- PersonAlois Alzheimer
Shares Alzheimer’s disease and the tag dementia-atlas.
- TreatmentBrexpiprazole
Shares Alzheimer’s disease and the tag dementia-atlas.
- CollectionClinicalTrials.gov
Shares Alzheimer’s disease and the tag dementia-atlas.
- TreatmentMemantine
Shares Alzheimer’s disease and the tag dementia-atlas.
- InstitutionNational Institute on Aging
Shares Alzheimer’s disease and the tag dementia-atlas.
- TechnologyCSF amyloid and tau
Shares Alzheimer’s disease and the tag dementia-atlas.
- InstitutionUCL
Shares Alzheimer’s disease and the tag dementia-atlas.
